A note about authorship, MTAs, IP and other matters related to DREADDs


As should be evident to all (though I still get queries about this) DREADD technology is open source with no associated intellectual property (IP)-encumbrances. There is no need for an MTA to use/obtain the technology*.

The technology is not patented and is given freely to the scientific community without restrictions as to use.  Future enhancements also will never be patented by me.

This means that if you make a 'non-obvious enhancement' you conceivably could patent it.

What this means is that you can obtain the *cDNAs from ADDGENE, *mice from JAX and viruses from UNC and use them for whatever purposes you desire without permission from my lab.  This includes pharma/biotech.


As a general rule not include me or any member of my lab as authors on your papers using DREADD technology simply because we shared a reagent with you or offered you helpful advice (e.g. how to dissolve CNO).  If you are unsure, please discuss with us before you submit the paper (or send in a presubmission inquiry).


Generally not needed (though see *).

*Known exceptions:  JAX will likely require a license for use of mice from commercial entities though use is not restricted.  I believe ADDGENE requires an MTA of sorts for all plasmids it ships.


Popular posts from this blog

How best to dissolve CNO ...it depends on what it is soluble in (and that depends on the particular polymorph)